FDA Inspection 1191693 — Lancaster General Blood Donor Center
The FDA completed an inspection of Lancaster General Blood Donor Center on November 10, 2022 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 10, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Lancaster, PA (United States)